Neogen Chemicals: Promoter Haridas Thakarshi Kanani Gifts 21.90% Stake to Family Trusts
Promoter Haridas Thakarshi Kanani gifted 57,78,500 equity shares (21.90%) of Neogen Chemicals to Haridas Kanani Family Trust and H T Kanani Family Trust on December 31, 2025. This off-market transfer falls under SEBI's exemption order. Promoter and promoter group holding remains unchanged.
While the overall promoter holding remains the same, a significant portion of shares has been transferred between related entities. This may impact the perception of share distribution and future strategic decisions, warranting a medium impact assessment.
The transaction is an inter-se transfer of shares within the promoter group via gift, with no change in the overall promoter holding. Therefore, it has a neutral impact on the company's fundamentals.
Neogen Chemicals Limited has announced an inter-se transfer of 57,78,500 equity shares, representing 21.90% of the company's paid-up equity share capital, from Promoter Haridas Thakarshi Kanani to Haridas Kanani Family Trust and H T Kanani Family Trust. This transaction was executed as a gift through an off-market transfer on December 31, 2025.
The disclosure was made pursuant to Regulation 29(2) and 29(1) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The aggregate holding of the Promoter and Promoter group category remains unchanged before and after this transaction.
This transfer is in accordance with an exemption granted by SEBI under Regulation 11(5) of the SAST Regulations, as detailed in SEBI's exemption order no. WTM/KCV/CFD/17/2025-26 dated December 30, 2025. Following the acquisition, Haridas Kanani Family Trust will be classified as a Promoter shareholder, and H T Kanani Family Trust as a Promoter Group shareholder.
What to do with a filing like this
Neogen Chemicals Limited filed this with the NSE as a statutory disclosure, categorised under substantial acquisition of shares and takeovers. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Neogen Chemicals Limited. Read the original for the full detail.